Fig. 6From: The potential impact of the demographic transition in the Senegal-Gambia region of sub-Saharan Africa on the burden of infectious disease and its potential synergies with control programmes: the case of hepatitis BPotential synergy between demographic transition and HBV vaccination under different projection variants. Reconstructed and projected overall population burden of HBV disease (over the entire course of the DT up to 2150) without and with vaccination commencing in 2005: a the case of UN medium variant; b a worst-case scenario where fertility remains constant at its maximum level. Vaccination is administered at age 3.5 months assuming 100% efficacyBack to article page